All the Active Ingredient Drugs
Gazyva
Roche
Gazyva
Monoclonal Antibody. Obinutuzumab 1000 mg / 40 ml. VIAL (conc. for sol. for infus.): 1 x 1000
mg/ 40 mL. Durat. of tmt.- 6 tmt. cycles, each of 28 days. 1st cycle: The 1,000 mg admin. over 1st day and 2nd day, and on 8th day and 15th day of the first 28 day tmt. cycle. If there are any modific.of the infus. rate or interrupt. during the first 100 mg the 2nd bag must be admin. the follow.
day. 2nd to 6th Cycles: 1,000 mg admin. on 1st day. See lit.
In comb.with Chlorambucil, indic. for the
tmt. of pts. with previously untreated
Chronic Lymphocytic Leukemia (CLL).
C/I: Hypersens.